Structure Therapeutics (GPCR) Amortizatization of Intangibles (2022 - 2026)
Quarterly Amortizatization of Intangibles fell 99.81% to $10000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$4.8 million through Mar 2026, down 351.66% year-over-year, with the annual reading at $345000.0 for FY2025, 8525.0% up from the prior year.
Structure Therapeutics' Amortizatization of Intangibles history spans 5 years, with the latest figure at $10000.0 for Q1 2026.
- Amortizatization of Intangibles came in at $10000.0 for Q1 2026, down from $322000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $5.2 million in Q1 2025 to a low of -$9.5 million in Q3 2025.
- The 5-year median for Amortizatization of Intangibles is $322000.0 (2025), against an average of $75588.2.
- Year-over-year, Amortizatization of Intangibles crashed 859.41% in 2023 and then surged 4700.0% in 2025.
- Structure Therapeutics' Amortizatization of Intangibles stood at $478000.0 in 2022, then plummeted by 859.41% to -$3.6 million in 2023, then skyrocketed by 99.81% to -$7000.0 in 2024, then soared by 4700.0% to $322000.0 in 2025, then plummeted by 96.89% to $10000.0 in 2026.
- Per Business Quant, the three most recent readings for GPCR's Amortizatization of Intangibles are $10000.0 (Q1 2026), $322000.0 (Q4 2025), and -$9.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | 10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,000.00 |
| Mar 31, 2026 | 10,000.00 |
| Dec 31, 2025 | 322,000.00 |
| Dec 31, 2025 | 322,000.00 |
| Sep 30, 2025 | -9.51 Mn |
| Sep 30, 2025 | -9.51 Mn |
| Jun 30, 2025 | 4.34 Mn |
| Jun 30, 2025 | 4.34 Mn |
| Mar 31, 2025 | 5.20 Mn |
| Mar 31, 2025 | 5.20 Mn |
| Dec 31, 2024 | -7,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Sep 30, 2024 | -6.45 Mn |
| Sep 30, 2024 | -6.45 Mn |
| Jun 30, 2024 | 3.18 Mn |
| Jun 30, 2024 | 3.18 Mn |
| Mar 31, 2024 | 3.28 Mn |
| Mar 31, 2024 | 3.28 Mn |
| Dec 31, 2023 | -3.63 Mn |
| Dec 31, 2023 | -3.63 Mn |
| Sep 30, 2023 | 1.66 Mn |
| Sep 30, 2023 | 1.66 Mn |
| Jun 30, 2023 | 1.64 Mn |
| Jun 30, 2023 | 1.64 Mn |
| Mar 31, 2023 | 346,000.00 |
| Mar 31, 2023 | 346,000.00 |
| Dec 31, 2022 | 478,000.00 |
| Dec 31, 2022 | 478,000.00 |
| Sep 30, 2022 | 280,000.00 |
| Sep 30, 2022 | 280,000.00 |
| Jun 30, 2022 | 130,000.00 |
| Jun 30, 2022 | 130,000.00 |
| Mar 31, 2022 | 17,000.00 |
| Mar 31, 2022 | 17,000.00 |